1. bookVolume 27 (2019): Issue 1 (January 2019)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Ischemia modified albumin in experimental ovarian torsion with and without controlled reperfusion

Published Online: 01 Feb 2019
Page range: 43 - 50
Received: 08 Nov 2018
Accepted: 28 Dec 2018
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Purpose: Ovarian torsion, being a gynecological emergency, requires to be rapidly diagnosed and treated with minimal consequences on ovarian function after the removal of torsion. As ischemia modified albumin (IMA) is considered a good biomarker in diverse ischemic diseases, the aim of our study was to determine the effect of different ovarian torsion/detorsion models on serum and ovarian homogenates levels of IMA in an experimental study.

Methods: IMA was measured in the serum and ovarian homogenates of 7 groups of female rats (10 animals in each group): 1 - control (no intervention); 2 - sham (only laparotomy); 3 - ischemia group: 3 hours ovarian torsion (OT); 4 - 3 hours OT (ischemia), 1 hour simple reperfusion; 5 - 3 hours ischemia, 1 hour controlled reperfusion that was assured during the first two minutes by opening and closing the clips on the ovarian pedicles in 10 seconds intervals, followed by simple reperfusion; 6 - 3 hours ischemia, 24 hours simple reperfusion; 7 - 3 hours OT, 24 hours controlled reperfusion. The results were analyzed by Welch’s ANOVA and Spearman correlation.

Results: Ischemia increases the IMA in both serum and ovarian homogenates compared to control and sham groups. The controlled reperfusion groups had a statistically significant lower IMA in serum compared to simple reperfusion groups. IMA was found to be higher in the ovarian homogenates of simple reperfusion compared to controlled reperfusion groups.

Conclusion: Our results suggest that controlled reperfusion prevent the processes that increase the IMA in ovarian torsion.

Keywords

1. McCloskey K, Grover S, VuillerminBabl FE. Ovarian torsion among girls presenting with abdominal pain: a retrospective cohort study. Emerg Med J. 2013; 30(1):e11. DOI: 10.1136/emermed-2011-20020010.1136/emermed-2011-20020022345311Open DOISearch in Google Scholar

2. Karatas Gurgun A, Kaban I, Aka N, Mentese A, Aker F, Uras AR. The Role of ischemia Modified Albumin and D-dimer as Early or Late Biochemical Markers in Ovarian Torsion. J Obstet Gynaecol Res. 2017; 43(5):895-901. DOI: 10.1111/jog.1328110.1111/jog.1328128190281Open DOISearch in Google Scholar

3. Tuncer AA, Bozkurt MF, Koken T, Dogan N, Pektaş MK, Baskin Embleton D. The Protective Effects of Alpha-Lipoic Acid and Coenzyme Q10 Combination on Ovarian Ischemia-Reperfusion Injury: An Experimental Study. Adv Med. 2016; 2016:3415046. DOI: 10.1155/2016/341504610.1155/2016/3415046500246727597986Search in Google Scholar

4. Zucchini S, Marra E. Diagnosis of emergencies/urgencies in gynecology and during the first trimester of pregnancy. J Ultrasound. 2014; 17(1):41-6. DOI: 10.1007/s40477-013-0059-010.1007/s40477-013-0059-0394519024616750Open DOISearch in Google Scholar

5. Childress KJ, Dietrich JE. Pediatric ovarian torsion. Surg Clin North Am. 2017; 97(1):209-21. DOI: 10.1016/j.suc.2016.08.00810.1016/j.suc.2016.08.00827894428Open DOISearch in Google Scholar

6. Spinelli C, Piscioneri J, Strambi S. Adnexal torsion in adolescents: update and review of the literature. Curr Opin Obstet Gynecol. 2015; 27(5):320-5. DOI: 10.1097/GCO.000000000000019710.1097/GCO.000000000000019726204167Open DOISearch in Google Scholar

7. Karaman E, Beger B, Çetin O, Melek M, Karaman Y. Ovarian Torsion in the Normal Ovary: A Diagnostic Challenge in Postmenarchal Adolescent Girls in the Emergency Department. Med Sci Monit. 2017; 23:1312-6. DOI: 10.12659/MSM.90209910.12659/MSM.902099Search in Google Scholar

8. BolliSchädelin S, Holland-Cunz S, ZimmermannOvarian torsion in children: Development of a predictive score. Medicine. 2017; 96(43):e8299. DOI: 10.1097/MD.000000000000829910.1097/MD.0000000000008299567183329069000Search in Google Scholar

9. Aran T, Guven S, Unsal MA, Alver A, Mentese A, Yulug E. Serum ischemia-modified albumin as a novel marker of ovarian torsion: an experimental study. Eur J Obstet Gynecol Reprod Biol. 2010; 150(1):72-5. DOI: 10.1016/j.ejogrb.2010.01.00610.1016/j.ejogrb.2010.01.00620172646Open DOISearch in Google Scholar

10. Guven S, Kart C, Guven ESG, Cetin EC, Menteşe A. Is the measurement of serum ischemia-modified albumin the best test to diagnose ovarian torsion? Gynecol Obstet Invest. 2015; 79(4):269-75. DOI: 10.1159/00036778710.1159/00036778725591981Search in Google Scholar

11. Laganà AS, Sofo V, Salmeri FM, Palmara VI, Triolo O, Terzić MM, et al. Oxidative stress during ovarian torsion in pediatric and adolescent patients: changing the perspective of the disease. Int J Fertil Steril. 2016; 9(4):416-23.Search in Google Scholar

12. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell Biology of Ischemia/Reperfusion Injury. Int Rev Cell Mol Biol. 2012; 298:229–317. DOI: 10.1016/B978-0-12-394309-5.00006-710.1016/B978-0-12-394309-5.00006-7390479522878108Open DOISearch in Google Scholar

13. Żurawska-Płaksej E, Grzebyk E, Marciniak D, Szymańska-Chabowska A, Piwowar A. Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Invest. 2014; 37(9):819-27. DOI: 10.1007/s40618-014-0111-810.1007/s40618-014-0111-8415960124957167Open DOISearch in Google Scholar

14. Mertoglu C, Gunay M, Gurel A, Gungor M, Gul V. Ischemic modified albumin increases in acute kidney injury. Rev Romana Med Lab. 2018; 26(1):37-43. DOI: 10.2478/rrlm-2018-000210.2478/rrlm-2018-0002Open DOISearch in Google Scholar

15. Shen XL, Lin CJ, Han LL, Lin L, Pan L,XD. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol. 2011; 149(3):296-8. DOI: 10.1016/j.ij-card.2010.01.013Search in Google Scholar

16. Gaze DC. Ischemia Modified Albumin: a novel bio-marker for the detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009; 24(4):333-41. DOI: 10.2133/dmpk.24.33310.2133/dmpk.24.33319745560Open DOISearch in Google Scholar

17. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocar-dial ischemia. Eur J Biochem. 2001; 268(1):42-7. DOI: 10.1046/j.1432-1327.2001.01846.x10.1046/j.1432-1327.2001.01846.x11121100Open DOISearch in Google Scholar

18. Liyan C, Jie Z, Yonghua W, Xiaozhou H. Assay of ischemia-modified albumin and c-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal. 2008; 22(1):45-9. DOI: 10.1002/jcla.2022310.1002/jcla.20223664893118200582Open DOISearch in Google Scholar

19. Yildirim A, Yildirim S, Topaloglu N, Tekin M, Kucuk A, Erdem H, et al. Correlation of ischemia-modified albumin levels and histopathologic findings in experimental ovarian torsion. Turk J Emerg Med. 2016; 16(1):8-11. DOI: 10.1016/j.tjem.2016.02.00410.1016/j.tjem.2016.02.004488219327239631Open DOISearch in Google Scholar

20. Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol. 2006; 108(3):410-11. DOI: 10.1016/j.ijcard.2005.03.04010.1016/j.ijcard.2005.03.04016520132Open DOISearch in Google Scholar

21. Marx G, Chevion M. Site-specific modification of albumin by free radicals. Reaction with copper (II) and ascorbate. Biochem J. 1986; 236(2):397-400. DOI: 10.1042/bj236039710.1042/bj236039711468533753454Open DOISearch in Google Scholar

22. Gudumac V, Tagadiuc O. Metodă de determinare a capacității albuminei ischemic modificate de legare a cobaltului. Brevet de invenție nr. MD 4054 din 11.06.2009 http://www.db.agepi.md/Inventions/details/a%202009%200116/Des~a%202009%200116.Search in Google Scholar

23. Ingec M, Isaoglu U, Yilmaz M, Calik M, Polat B, Alp HH, et al. Prevention of ischemia-reperfusion injury in rat ovarian tissue with the on-off method. J Physiol Pharmacol. 2011; 62(5):575-82.Search in Google Scholar

24. Ozkisacik S, Yazici M, Gursoy H, Culhaci N. Does gradual detorsion protect the ovary against ischemia-reperfusion injury in rats? Pediatr Surg Int. 2014; 30(4):437-40. DOI: 10.1007/s00383-014-3480-310.1007/s00383-014-3480-324519483Open DOISearch in Google Scholar

25. Gencer M, Karaca T, Güngör AN, Hacıvelioğlu SÖ, Demirtaş S, Turkon H, et al. The protective effect of quercetin on IMA levels and apoptosis in experimental ovarian ischemia-reperfusion injury. Eur J Obstet Gynecol Reprod Biol. 2014; 177:135-40. DOI: 10.1016/j.ejogrb.2014.03.03610.1016/j.ejogrb.2014.03.03624793929Open DOISearch in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo